Top 5 Life Science Angel Investors in Canada in January 2026

Last updated: Jan 2026 A list of 5 angel investors that invest in Life science startups based in Canada. We rank investors based on the number of investments they made in Life science companies from Canada. We update this investor list every month.

Top 5 Life Science Angel Investors in Canada in January 2026

Investor	Life Science Canada investments
Balaji Srinivasan	2
Jed McCaleb	1
Dan Schultz	1
Rami Essaid	1
Joe Betts-Lacroix	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. He was previously CEO at Earn.com, which was recently sold to Coinbase. Prior to taking the CEO role at Earn.com, Dr. Srinivasan was a General Partner at Andreessen Horowitz. Prior to joininga16z, he was the co-founder and CTO of Founders Fund-backed Counsyl, where he won the Wall Street Journal Innovation Award for Medicine and was named to the MIT TR35. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including an online MOOC in 2013 which reached 250,000+ students worldwide.

Investment focus

Blockchain, Cryptocurrency, Software
Seed, Pre-Seed, Series A
United States, India, Singapore

Portfolio highlights

Blitz Electric Mobility — Blitz provides electric vehicles and fleet management software to food and beverage delivery, courier, and logistics companies.
Paradigm — The AI-powered way to do spreadsheet work. Set up, edit, populate, and analyze sheets with assistant. Enrich empty cells with data from trusted sources.
Inversion — Inversion is a technology-first investment company that acquires and transforms legacy businesses with blockchain technology.

Jed McCaleb is based out of San Francisco, California and is the Founder of Vast. Jed previously worked at Ripple as a Co-Founder.

Investment focus

Internet, Payments, SaaS
Seed, Series A, Initial Coin Offering
United States, Canada

Portfolio highlights

Bold Financial Technologies — Bold Financial Technologies is a payment and compliance operations for on-demand service operators. It's payouts stack to pay new publishers globally offers a REST API integration, from background checks to driving record screening and local currency payouts; and provides Bold Payouts platform, a solution for marketplaces to leverage a singleintegration that offers a back-office payout infrastructure.Bold Financial Technologies streamlines the process of mass payouts while exponentially growing the international reach of its clients. It also provides a complete administrative platform, including Tax tracking and reporting, recipient onboarding, a client administrative portal, a recipient portal, and an API.It was founded in 2014 and is headquartered in San Francisco, California.
Stream Token — Stream is a new decentralized blockchain-based token that allows livestreamers to easily and anonymously accept payments from their audience members anywhere in the world, with extremely low transaction fees and no platform lock-in.
Propellon Therapeutics — Propellon Therapeutics is developing and commercializing novel cancer therapies targeting the WDR5 protein, essential for assembly of methyltransferase complexes and proper histone modification. The overexpression of WDR5 and resulting deregulation of epigenetic mechanisms are implicated in various cancers and correlated with poor patient survival.Established by FACIT, Propellon’s WDR5 inhibitor platform arises from discoveries, research and innovations originating from OICR.

Dan Schultz

Investment focus

SaaS, Data Mining, Life Science
Seed
Canada, United States

Portfolio highlights

Prospectify — #1 trusted site to buy youtube subscribers India. Offer high quality, safe and legit buy youtube subscribers cheap prices and order starts in 24-48 Hrs
Propellon Therapeutics — Propellon Therapeutics is developing and commercializing novel cancer therapies targeting the WDR5 protein, essential for assembly of methyltransferase complexes and proper histone modification. The overexpression of WDR5 and resulting deregulation of epigenetic mechanisms are implicated in various cancers and correlated with poor patient survival.Established by FACIT, Propellon’s WDR5 inhibitor platform arises from discoveries, research and innovations originating from OICR.

Rami Essaid is the Co-Founder and Chief Executive Officer of Finmark, a Venture Partner at IDEA Fund Partners, and an Extended Team Member of Ubiquity Ventures. He was the Co-Founder and Chairman of Distil. Rami helps enterprises embrace the cloud to improve their scalability and reliability while maintaining a high level of security.He attendedNorth Carolina State University where he majored in computer engineering.